Validation Study of the Simplified Seizure Classification Algorithm

NCT03796520 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2021-02-17

No results posted yet for this study

Summary

An algorithm has been developed for simplified classification of epileptic seizures, in order to optimize choice of antiepileptic drugs.

The objective of this study was to clinically validate the algorithm.

Conditions

Interventions

DIAGNOSTIC_TEST

EpiPick simplified seizure classification algorithm

EpiPick simplified seizure classification algorithm input: Grey matter brain lesion Exclusively nocturnal seizures First seizure at age \> 20 years Lip smacking or chewing during seizures Staring with impaired awareness, lasting less than 20s without postictal confusion Sudden irregular jerks, in isolation or brief series, if none of the following applies: Are the jerks consistently in the same limb? When resting in bed when falling asleep? Bilateral tonic-clonic seizures within 1h of awakening or immediately preceded by irregular jerks Any of the following is present: Skin turning pale pre-ictally; Loss of consciousness immediately after urination or defecation; Sudden slump with loss of awareness, lasting less than 10 seconds; Seizure lasting longer than 10 minutes, with eyes closed throughout the seizure; Severe pre-ictal headache; Episodes consisting of falls that occur always after change in posture to the upright position, or coughing or feeling pain.

Sponsors & Collaborators

  • Danish Epilepsy Centre

    collaborator UNKNOWN
  • Shiraz University of Medical Sciences

    collaborator OTHER
  • University of Pavia

    collaborator OTHER
  • Thomas Jefferson University

    collaborator OTHER
  • Sándor Beniczky

    lead OTHER

Principal Investigators

  • Sandor Beniczky, MD, PhD · Aarhus University Hospital

  • Guido Rubboli, MD, PhD · Danich Epilepsy Centre

  • Michael Sperling, MD, PhD · Thomas Jefferson University

  • Emilio Perucca, MD, PhD · University of Pavia

  • Ali A Asadi-Pooya, MD, PhD · Shiraz University of Medical Sciences

Eligibility

Min Age
10 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-02
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • United States
  • Denmark
  • Iran
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03796520 on ClinicalTrials.gov